Skip to Content


In the US, Keveyis (dichlorphenamide systemic) is a member of the drug class carbonic anhydrase inhibitors and is used to treat Hyperkalemic Periodic Paralysis, Hypokalemic Periodic Paralysis and Primary Periodic Paralysis.

US matches:

Ingredient matches for Keveyis


Diclofenamide is reported as an ingredient of Keveyis in the following countries:

  • United States

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.